Search results
Some hawking stem cells say they can treat almost anything. They can’t
WWTI Watertown· 1 day agoThe mailings promised “Life Without Pain!” via stem cell injections or IVs administered in a...
Low-income Floridians with sickle cell disease will have access to new gene therapies
Florida Phoenix via Yahoo News· 7 hours agoNow, Floridians with sickle cell disease are closer to a functional cure after health care officials...
FDA APPROVES BLINCYTO® (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL...
Morningstar· 2 days agoAmgen (NASDAQ:AMGN) today announced the U.S. Food and Drug Administration (FDA) has approved BLINCYTO® (blinatumomab) for the treatment of adult and pediatric patients one ...
Ticker: FAA investigates another Boeing 737 Max, this time for ‘dutch roll’ mid-flight
Boston Herald· 21 hours agoThe FAA said the plane went into a “Dutch roll,” the name given to the combination of a yawing...
BCLI: Initiation - Potential 10x Return on Successful Phase 3b. Promising Post Hoc and Biomarker...
The Woonsocket Call· 2 days agoINITIATION NOTE: BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI) is focused on developing autologous mesenchymal stem cell (MSC) therapies ...
Mike Tyson uses health treatments lacking FDA approval as part of non-traditional approach
USA Today· 1 day agoMike Tyson has released videos showing he still can punch with power. At 57, Tyson must recover from...
Vertex says Casgevy benefit extends to nearly five years in sickle cell disease
Clinical Trials Arena via Yahoo Finance· 2 days agoVertex said in a statement: “The efficacy results are consistent with the previously reported...
Risk of secondary cancers after CAR-T cell therapy low, according to large study
Science Daily· 4 days agoIn November 2023, the FDA issued a warning about a risk of secondary cancers -- particularly blood cancers -- that may be associated with CAR-T cell therapy ...
...STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or...
Morningstar· 1 day agoGenentech’s Phase III STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma – The study met ...
Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare case
Live Science via Yahoo News· 3 days agoSecondary cancers are known to occur in 4% to 16% of people following chemotherapy and radiation...